Activated protein C resistance in homozygous sickle cell disease

British Journal of Haematology

Volumn 96, Issue 4, 1997, Pages 854-856

  Wright, J G ^c,d   Cooper, P ^a   Malia, K G ^a   Kulozik, A E ^b   Vetter, B ^b   Thomas, P ^c   Preston, F H ^a   Serjeant, G R ^c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

activated protein C resistance; dilute Russell Viper venom time; factor V Leiden; homozygous sickle cell disease

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; SICKLE CELL ANEMIA;

EID: 0031056403     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2084.x     Document Type: Article

References (12)

1. Bertina, R.M., Koelman, B.P.C., Kosten, T., Rosendaal, RR., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-68.
2. Cumming, A.M., Tait, R.C., Fildes, S., Yoong, A., Keeney, S. & Hay, C.R.M. (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology, 90, 725-727.
3. Dahlback, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by a poor response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
4. DeCeulacr, K., Khamashta, M.A., Harris, N.E., Serjeant, G.R. & Hughes, G.R.V. (1992) Antiphospholipid antibodies in homozygous sickle cell disease. Annals of the Rheumatic Diseases, 51, 671-672.
5. Francis, R.B. (1992) Platelets coagulation and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagulation and Fibrinolysis, 2, 341-353.
6. Henkens, C.M.A., Bom, V.J.J. & van der Meer, J. (1995) Lowered APC-sensitivity ratio related to increased factor VIII clotting activity. Thrombosis and Haemostssis, 74, 1198-1199.
7. Lupus Anticoagulant Working Party on belalf of BCSH (1991) Guidelines on testing for the lupus anticoagulant. Journal of Clinical Pathology, 44, 885-889.
8. Osterud, B., Robertson, R., Asvang, G.B. & Thijsseen, F. (1994) Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagulation and Fibrinolysis, 5, 853-854.
9. Rai, R., Regan, L., Hadley, E., Dave, M. & Cohen, H. (1996) Second trimester pregnancy loss is associated with activated protein C resistance. British Journal of Haematology, 92, 489-490.
10. Rees, D.S., Cox, M. & Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
11. Richardson. S.G.N., Matthews, K.B., Stuart, J., Geddes, A.M. & Wilcox, R.M. (1979) Serial changes in coagulation and viscosity during sickle cell crisis. British Journal of Haematology, 41, 95-103.
12. Simioni, P., Scarano, L., Gavasso, S., Sardella, C., Girolami, B., Scudeller, A. & Girolami, A. (1996) Prothrombin fragment 1 + 2 and thrombin - antithrombin complex levels in patients with inherited activated protein C resistance due to factor V Leiden mutation. British Journal of Haematology, 92, 455-441.